{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:33:15Z","timestamp":1776954795001,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00391-025-02416-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:13:40Z","timestamp":1740482020000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gicht","Gout"],"prefix":"10.1007","volume":"58","author":[{"given":"Vanessa","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Standfest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Hueber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"7","key":"2416_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans\u00a0L, Spaepen\u00a0E, Gaskin\u00a0M, Bonnemaire\u00a0M, Malier\u00a0V, Gilbert\u00a0T et\u00a0al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis 67(7):960","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2416_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/acr2.11172","volume":"2","author":"C Pecherstorfer","year":"2020","unstructured":"Pecherstorfer\u00a0C, Simon\u00a0D, Unbehend\u00a0S, Ellmann\u00a0H, Englbrecht\u00a0M, Hartmann\u00a0F et\u00a0al (2020) A\u00a0detailed analysis of the association between Urate deposition and erosions and osteophytes in gout. Acr Open Rheumatol 2(10):565\u2013572","journal-title":"Acr Open Rheumatol"},{"issue":"2","key":"2416_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/art.1780150209","volume":"15","author":"JN Loeb","year":"1972","unstructured":"Loeb\u00a0JN (1972) The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 15(2):189\u2013192","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2416_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005","volume":"23","author":"J Desai","year":"2017","unstructured":"Desai\u00a0J, Steiger\u00a0S, Anders\u00a0HJ (2017) Molecular pathophysiology of gout. Trends Mol Med 23(8):756\u2013768","journal-title":"Trends Mol Med"},{"issue":"suppl\u00a02","key":"2416_CR5","first-page":"ii2","volume":"48","author":"M Doherty","year":"2009","unstructured":"Doherty\u00a0M (2009) New insights into the epidemiology of gout. Rheumatology 48(suppl\u00a02):ii2\u2013ii8","journal-title":"Rheumatology"},{"issue":"7","key":"2416_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2009.109884","volume":"69","author":"AE Hak","year":"2010","unstructured":"Hak\u00a0AE, Curhan\u00a0GC, Grodstein\u00a0F, Choi\u00a0HK (2010) Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 69(7):1305\u20131309","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2416_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","volume":"50","author":"JA Singh","year":"2020","unstructured":"Singh\u00a0JA, Gaffo\u00a0A (2020) Gout epidemiology and comorbidities. Semin Arthritis Rheum 50(3):S11\u2013S16","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2416_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/art.41067","volume":"72","author":"HK Choi","year":"2020","unstructured":"Choi\u00a0HK, McCormick\u00a0N, Lu\u00a0N, Rai\u00a0SK, Yokose\u00a0C, Zhang\u00a0Y (2020) Population impact attributable to modifiable risk factors for hyperuricemia. Arthritis Rheumatol 72(1):157\u2013165","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"2416_CR9","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3899\/jrheum.171320","volume":"45","author":"N Zleik","year":"2018","unstructured":"Zleik\u00a0N, Elfishawi\u00a0MM, Kvrgic\u00a0Z, Michet\u00a0CJ, Crowson\u00a0CS, Matteson\u00a0EL et\u00a0al (2018) Hospitalization increases the risk of acute arthritic flares in gout: a\u00a0population-based study over 2 decades. J\u00a0Rheumatol 45(8):1188\u20131191","journal-title":"J Rheumatol"},{"issue":"7","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth\u00a0N, Phipps-Green\u00a0A, Frampton\u00a0C, Neogi\u00a0T, Taylor\u00a0WJ, Merriman\u00a0TR (2018) Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis 77(7):1048\u20131052","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2416_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3899\/jrheum.190346","volume":"47","author":"MM Elfishawi","year":"2020","unstructured":"Elfishawi\u00a0MM, Zleik\u00a0N, Kvrgic\u00a0Z, Michet\u00a0CJ, Crowson\u00a0CS, Matteson\u00a0EL et\u00a0al (2020) Changes in the presentation of incident gout and the risk of subsequent flares: a\u00a0population-based study over 20 years. J\u00a0Rheumatol 47(4):613\u2013618","journal-title":"J Rheumatol"},{"issue":"12","key":"2416_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3346\/jkms.2017.32.12.1967","volume":"32","author":"JH Lee","year":"2017","unstructured":"Lee\u00a0JH, Yang\u00a0JA, Shin\u00a0K, Lee\u00a0GH, Lee\u00a0WW, Lee\u00a0EY et\u00a0al (2017) Elderly patients exhibit stronger inflammatory responses during gout attacks. J\u00a0Korean Med Sci 32(12):1967","journal-title":"J Korean Med Sci"},{"issue":"1","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","volume":"24","author":"N Bellamy","year":"1987","unstructured":"Bellamy\u00a0N, Downie\u00a0W, Buchanan\u00a0W (1987) Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol 24(1):33\u201336","journal-title":"Br J Clin Pharmacol"},{"key":"2416_CR14","doi-asserted-by":"crossref","unstructured":"Uhlig T, Karoliussen LF, Sexton J, Provan SA, Haavardsholm EA, Dalbeth N et\u00a0al (2024) Non-adherence to urate lowering therapy in gout after 5\u00a0years is related to poor outcomes\u2014results from the NOR-Gout study. Rheumatology","DOI":"10.1093\/rheumatology\/keae514"},{"issue":"1","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-007-0421-7","volume":"28","author":"F De Leonardis","year":"2007","unstructured":"De Leonardis\u00a0F, Govoni\u00a0M, Colina\u00a0M, Bruschi\u00a0M, Trotta\u00a0F (2007) Elderly-onset gout: a\u00a0review. Rheumatol Int 28(1):1","journal-title":"Rheumatol Int"},{"issue":"6","key":"2416_CR16","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10067-020-04947-2","volume":"39","author":"B Lu","year":"2020","unstructured":"Lu\u00a0B, Lu\u00a0Q, Huang\u00a0B, Li\u00a0C, Zheng\u00a0F, Wang\u00a0P (2020) Risk factors of ultrasound-detected tophi in patients with gout. Clin Rheumatol 39(6):1953\u20131960","journal-title":"Clin Rheumatol"},{"issue":"9","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3899\/jrheum.081128","volume":"36","author":"T Shimizu","year":"2009","unstructured":"Shimizu\u00a0T, Hori\u00a0H (2009) The prevalence of nephrolithiasis in patients with primary gout: a\u00a0cross-sectional study using helical computed tomography. J\u00a0Rheumatol 36(9):1958\u20131962","journal-title":"J Rheumatol"},{"key":"2416_CR18","doi-asserted-by":"crossref","unstructured":"Shekarriz B, Stoller ML (2002) Uric acid nephrolithiasis: current concepts and controversies. J\u00a0Urol: 1307\u20131314","DOI":"10.1097\/00005392-200210010-00003"},{"issue":"6","key":"2416_CR19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3899\/jrheum.080938","volume":"36","author":"N Schlesinger","year":"2009","unstructured":"Schlesinger\u00a0N, Norquist\u00a0JM, Watson\u00a0DJ (2009) Serum urate during acute gout. J\u00a0Rheumatol 36(6):1287\u20131289","journal-title":"J Rheumatol"},{"issue":"1","key":"2416_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P Richette","year":"2020","unstructured":"Richette\u00a0P, Doherty\u00a0M, Pascual\u00a0E, Barskova\u00a0V, Becce\u00a0F, Castaneda\u00a0J et\u00a0al (2020) 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79(1):31\u201338","journal-title":"Ann Rheum Dis"},{"key":"2416_CR21","unstructured":"Deutsche Gesellschaft f\u00fcr Rheumatologie und Klinische Immunologie e.\u202fV. (DGRh) (2024) Diagnostik und Therapie der Gicht. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/060-005 (Erstellt: 10.2024)"},{"issue":"10","key":"2416_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi\u00a0T, Jansen\u00a0TLTA, Dalbeth\u00a0N, Fransen\u00a0J, Schumacher\u00a0HR, Berendsen\u00a0D et\u00a0al (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789\u20131798","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2416_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jbspin.2020.03.017","volume":"87","author":"R Sun","year":"2020","unstructured":"Sun\u00a0R, Lu\u00a0J, Li\u00a0H, Cheng\u00a0X, Xin\u00a0Y, Li\u00a0C (2020) Evaluation of febuxostat initiation during an acute gout attack: a\u00a0prospective, randomized clinical trial. Joint Bone Spine 87(5):461\u2013466","journal-title":"Joint Bone Spine"},{"issue":"11","key":"2416_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/art.24209","volume":"59","author":"HR Schumacher","year":"2008","unstructured":"Schumacher\u00a0HR, Becker\u00a0MA, Wortmann\u00a0RL, MacDonald\u00a0PA, Hunt\u00a0B, Streit\u00a0J et\u00a0al (2008) Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A\u00a028-week, phase\u00a0III, randomized, double-blind, parallel-group trial. Arthritis Care Res 59(11):1540\u20131548","journal-title":"Arthritis Care Res"},{"issue":"13","key":"2416_CR25","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White\u00a0WB, Saag\u00a0KG, Becker\u00a0MA, Borer\u00a0JS, Gorelick\u00a0PB, Whelton\u00a0A et\u00a0al (2018) Cardiovascular safety of febuxostat or allopurinol in patients with gout. N\u00a0Engl J Med 378(13):1200\u20131210","journal-title":"N Engl J Med"},{"issue":"10264","key":"2416_CR26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","volume":"396","author":"IS Mackenzie","year":"2020","unstructured":"Mackenzie\u00a0IS, Ford\u00a0I, Nuki\u00a0G, Hallas\u00a0J, Hawkey\u00a0CJ, Webster\u00a0J et\u00a0al (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a\u00a0multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet 396(10264):1745\u20131757","journal-title":"Lancet"},{"issue":"12","key":"2416_CR27","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1136\/ard-2023-224731","volume":"82","author":"L Stamp","year":"2023","unstructured":"Stamp\u00a0L, Horne\u00a0A, Mihov\u00a0B, Drake\u00a0J, Haslett\u00a0J, Chapman\u00a0PT et\u00a0al (2023) Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A\u00a0non-inferiority randomised double-blind placebo-controlled trial. Ann Rheum Dis 82(12):1626\u20131634","journal-title":"Ann Rheum Dis"},{"key":"2416_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew293","author":"BC Salem","year":"2016","unstructured":"Salem\u00a0BC, Slim\u00a0R, Fathallah\u00a0N, Hmouda\u00a0H (2016) Drug-induced hyperuricaemia and gout. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kew293","journal-title":"Rheumatology"},{"issue":"25","key":"2416_CR29","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1080\/10408398.2021.1911928","volume":"62","author":"B Nieradko-Iwanicka","year":"2022","unstructured":"Nieradko-Iwanicka\u00a0B (2022) The role of alcohol consumption in pathogenesis of gout. Crit Rev Food Sci Nutr 62(25):7129\u20137137","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2416_CR30","unstructured":"https:\/\/www.fachinfo.de\/fi\/detail\/000521\/allopurinol-abz-100-300-mg-tabletten"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-025-02416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:14:51Z","timestamp":1761326091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-025-02416-6"}},"subtitle":["Von der Diagnose zur leitliniengerechten Therapie","From the diagnosis to guideline-based treatment"],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s00391-025-02416-6","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"V.\u00a0Bartsch\n                      : A.\u00a0Finanzielle Interessen: V.\u00a0Bartsch gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin in Weiterbildung Rheumatologie, Abteilung Rheumatologie, Klinikum N\u00fcrnberg | Mitgliedschaften: Rheumazentrum Erlangen-N\u00fcrnberg e.\u202fV., Deutsche Gesellschaft f\u00fcr Rheumatologie und Immunologie.\n                      K.\u00a0Standfest\n                      : A.\u00a0Finanzielle Interessen: K.\u00a0Standfest gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Internistin, Assistenz\u00e4rztin in Weiterbildung Rheumatologie, Abteilung Rheumatologie, Klinikum N\u00fcrnberg | Mitgliedschaften: Rheumazentrum Erlangen-N\u00fcrnberg e.\u202fV., Deutsche Gesellschaft f\u00fcr Rheumatologie und Immunologie.\n                      A.\u00a0Hueber\n                      : A.\u00a0Finanzielle Interessen: A.\u00a0Hueber gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Abteilungsleiter Rheumatologie, Medizinische Klinik\u00a0V, Klinikum N\u00fcrnberg | Vorsitzender des Rheumazentrums Erlangen-N\u00fcrnberg e.\u202fV. | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie und Immunologie, Berufsverband Deutscher Rheumatologen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}